Stock Market news at lse.co.uk - RSS News Feeds

1spatial Holdings Share News (SPA)



Share News for 1spatial Holdings (SPA)


Share Price: 6.875Bid: 6.50Ask: 7.00Change: 0.125 (+1.85%)Riser - 1spatial
Spread: 0.50Spread as %: 7.69%Open: 6.75High: 6.725Low: 6.67Yesterday’s Close: 6.75




UK small caps open firmer, corporate news supporting

Fri, 23rd Jun 2006 09:32

LONDON (AFX) - UK small caps opened firmer with the wider market, a clutch of positive corpora
te news providing, dealers said

Overall gains were capped by profits warning from Sanctuary and Screen Technology, however, and by 9.11 am, the FTSE Small Cap index was just 0.6 up at 3,328.0, while the Footsie was 20.1 ahead at 5,704.2.

Among the winners, a swing to FY profits of 301,000 stg from losses of 15,000 stg lifted Capital Ideas 0.05 to 0.35 pence.

The group, which invests in private companies which are experiencing temporary distress, has made an encouraging start to the new year with the acquisition of shares in a hybrid low emission engine business in exchange for arranging the refinancing and restructuring.

Arc Risk Management rallied 0.07 to 0.62 following news of a reduction in full-year losses to 635,415 stg from 1.12 mln on the back of a 97 pct increase in turnover to 2.01 mln.

Executive chairman Simon Richards said the board's fundraising plans for the current year, which include the replacement of this debt finance in September, will continue to be influenced by the relationship between the share price and par value.

Buyers also came for Mediterranean Oil & Gas, 16-1/2 higher at 210-1/2, following news of an update to the resource estimates for the Company's Ombrina Mare oil and gas discovery.

And Vebnet Holdings jumped 10-1/2 to 157-1/2 after the employee benefit technology solutions concern disclosed that earnings before interest, taxes, depreciation and amortisation doubled in the 10 months to April 30.

Elsewhere, CybIT Holdings attracted support and rose 3 to 50 after the telematics service provider revealed a return to profit in the year to March 31 2006. It added that, in the coming year, it expects to increase market share in all sectors where it operates.

Nexus Management ticked up 0.05 to 0.87 as the provider of specialist IT managed services revealed that US-based Sapphire Technical Services and Atris Group have signed as agents to resell Nexus products to their existing and new customers.

In particular, the resellers will be focused on selling Nexus's recently

launched digital voice recording product, NexVR, which is already generating

significant interest among their customers, Nexus said.

meanwhile, SR Pharma edged up 1 to 14-1/4, a confident statement outweighing continuing full-year losses, while Churchill Mining moved ahead 1-1/2 to 30 as results from the company's Sendawar Coal Project in Indonesia confirmed the presence of high calorific coal.

Two newcomers to AIM made uninspiring debuts. Geong International, a leading provider of content management solutions software in China, stayed at its placing price of 30, while shares in Infoserve, which specialises in 'local search' marketing, were marked up to just 43 from a placing price of 41.15.

On the downside, troubled Sanctuary Group was again under pressure, sliding 10 more to 27-1/2, after the international music group warned that, after a review by the new management, it now expects to report an EBITDA loss of 17-22 mln stg for the year to Sept 30 2006.

Key findings from new management show that trading in the recorded product division in the current fiscal year to Sept 30 2006 will be below previous expectations, the disposal of various non-core assets is likely to take longer to complete than previously expected and further restructuring will be required.

Traders were also quick to exit Screen Technolgy, 7-1/2 lower at 35, after the board warned that sales for this year are likely to be significantly below current market expectations.

The sales forecast for 2006 was heavily dependent on the delivery of the new

high speed production machines and on the sale of modular products, the company said. The timing of both of these has been affected by delays by third party suppliers that will have a consequential impact on sales for 2006.

However, the board is confident that by the start of 2007, high speed tile production will be well underway and modular products will also be in production, supplying a very strong order book.



newsdesk@afxnews.com

fjb/vjt

COPYRIGHT
Copyright AFX News Limited 2005. All rights reserved.
The copying, republication or redistribution of AFX News Content, including by framing or similar means, is expressly prohibited without the prior written consent of AFX News.
AFX News and AFX Financial News Logo are registered trademarks of AFX News Limited







SR Pharma plans more pre-clinical Atu027 tests, gets AtuRNAi milestone payment

LONDON (Thomson Financial) - SR Pharma PLC said it intends to carry out more pre-clinical testing on its lead molecule Atu027, its first RNAi ca
[26 Apr '07]

SR Pharma chairman Iain Ross buys 100,000 shares in co at 75.75p each

LONDON (AFX) - SR Pharma PLC said chairman Iain Ross yesterday bought 100,000 shares at 75.75 pence each, giving him a 0.09 pct stake in the com
[3 Apr '07]

SR Pharma annual losses widen

LONDON (AFX) - SR Pharma PLC, which specialises in RNAi-based therapeutics, reported widening annual losses on higher research and development c
[30 Mar '07]

UK smallcap opening - Advent Air ticks up on interim profits surge

LONDON (AFX) - Advent Air ticked up 1/2 to 13-1/4 pence after the company revealed a 245 pct leap in first-half pretax profits on the back of gr
[16 Mar '07]

SR Pharma says FDA approves investigational application for second siRNA product

LONDON (AFX) - SR Pharma PLC said the US Food and Drug Administration has approved an Investigational New Drug application for a second small in
[16 Mar '07]

SR Pharma to get 1.5 mln usd milestone payment as blindness drug trial starts

LONDON (AFX) - Biopharmaceutical company SR Pharma PLC said it will get a 1.5 mln usd milestone payment to mark the start of a clinical trial on
[5 Feb '07]

SR Pharma to conduct full toxicological evaluation of RNAi candidate Atu027

LONDON (AFX) - Biopharmaceutical company SR Pharma PLC said it will proceed with a full, 28-day toxicological evaluation of its RNAi product can
[30 Jan '07]

RPT SR Pharma granted core RNAi patent by European Patent Office

(repeating to remove text from bottom of story) LONDON (AFX) - SR Pharma plc said the European Patent Office has granted the company its cor
[3 Jan '07]



Sign up for Live Prices





Datafeed and UK data supplied by NETbuilder and Interactive Data. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk!
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.